These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32721399)

  • 1. Cortical Hyperostosis after Long-Lasting Prostaglandin E1 Treatment in a Newborn with Complex Congenital Heart Disease.
    Celona A; Giardina C; Pappalardo S; Secinaro A; Oreto L; Agati S; Romeo P
    J Pediatr; 2020 Nov; 226():302-303. PubMed ID: 32721399
    [No Abstract]   [Full Text] [Related]  

  • 2. Cortical hyperostosis secondary to prolonged use of prostaglandin E1.
    de Almeida JF; Kimura H; Hercowitz LH; Korkes H; Troster EJ
    Clinics (Sao Paulo); 2007 Jun; 62(3):363-6. PubMed ID: 17589681
    [No Abstract]   [Full Text] [Related]  

  • 3. Cortical hyperostosis in an infant on prolonged prostaglandin infusion: case report and literature review.
    Velaphi S; Cilliers A; Beckh-Arnold E; Mokhachane M; Mphahlele R; Pettifor J
    J Perinatol; 2004 Apr; 24(4):263-5. PubMed ID: 15067299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical hyperostosis: a complication of prostaglandin E1 treatment in congenital heart disease.
    Smet MH; Marchal G; Lambert L; Devlieger H; Gewillig M
    J Belge Radiol; 1989 Oct; 72(5):377-80. PubMed ID: 2600053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversibility of cortical hyperostosis following long-term prostaglandin E1 therapy in infants with ductus-dependent congenital heart disease.
    Høst A; Halken S; Andersen PE
    Pediatr Radiol; 1988; 18(2):149-53. PubMed ID: 3281113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin induced cortical hyperostosis in neonates with cyanotic heart disease.
    Nadroo AM; Shringari S; Garg M; al-Sowailem AM
    J Perinat Med; 2000; 28(6):447-52. PubMed ID: 11155430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical hyperostosis simulating osteomyelitis after short-term prostaglandin E1 infusion.
    Kalloghlian AK; Frayha HH; deMoor MM
    Eur J Pediatr; 1996 Mar; 155(3):173-4. PubMed ID: 8929722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plain film and CT observations in prostaglandin-induced bone changes.
    Matzinger MA; Briggs VA; Dunlap HJ; Udjus K; Martin DJ; McDonald P
    Pediatr Radiol; 1992; 22(4):264-6. PubMed ID: 1523047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brown fat necrosis in the setting of congenital heart disease and prostaglandin E1 use: a case report.
    Raboi CA; Smith W
    Pediatr Radiol; 1999 Jan; 29(1):61-3. PubMed ID: 9880620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical hyperostosis as a side-effect of prolonged use of prostaglandins.
    Rivero Jiménez N; Bret-Zurita M; García-Guereta Silva L
    Cardiol Young; 2016 Jan; 26(1):149-50. PubMed ID: 26423344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E1 overdose in a term neonate with congenital heart disease.
    Gorodetsky RM; Toole BM; Schult RF; Wiegand TJ
    Clin Toxicol (Phila); 2019 Jun; 57(6):420-421. PubMed ID: 30451018
    [No Abstract]   [Full Text] [Related]  

  • 12. Complications of Long-Term Prostaglandin E1 Use in Newborns With Ductal-Dependent Critical Congenital Heart Disease.
    Alhussin W; Verklan MT
    J Perinat Neonatal Nurs; 2016; 30(1):73-9. PubMed ID: 26813395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical hyperostosis: a complication of prolonged prostaglandin infusion in infants awaiting cardiac transplantation.
    Woo K; Emery J; Peabody J
    Pediatrics; 1994 Mar; 93(3):417-20. PubMed ID: 8115200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E1: first stage palliation in neonates with congenital cardiac defects.
    Reddy SC; Saxena A
    Indian J Pediatr; 1998; 65(2):211-6. PubMed ID: 10771966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neonatal cortical hyperostosis. A side effect of prolonged prostaglandin E1 infusion].
    Fernández MA; Gebara E
    Arch Argent Pediatr; 2011 Apr; 109(2):154-9. PubMed ID: 21465075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertrichosis around a leg ulcer being treated with prostaglandin E1 ointment.
    Honda T; Koreeda S; Miyachi Y; Kabashima K
    J Am Acad Dermatol; 2011 Jun; 64(6):1212-3. PubMed ID: 21571200
    [No Abstract]   [Full Text] [Related]  

  • 17. Neonatal transport issues with prostaglandin E1 infusions.
    Grubbs TC; Kraft NL
    Air Med J; 2002; 21(3):8-12. PubMed ID: 11994726
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of low dose prostaglandin E1 treatment for ductus dependent congenital heart disease.
    Kramer HH; Sommer M; Rammos S; Krogmann O
    Eur J Pediatr; 1995 Sep; 154(9):700-7. PubMed ID: 8582419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal urticaria due to prostaglandin E1.
    Carter EL; Garzon MC
    Pediatr Dermatol; 2000; 17(1):58-61. PubMed ID: 10720990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E1 in infants with critical congenital heart disease.
    Dungan WT
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1985 Jan; 1(1):71-4. PubMed ID: 2454319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.